We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

I have one more round of TC to go before I start on four rounds of Perjeta and Herceptin, which blessedly are paid for with the kindness of crowdfunding. Each round will cost RM10,600 and what ...

Hence, the rising incidence of breast cancer is a crucial driver of the growth of the herceptin biosimilars market. Who Are The Major Industry Players In The Perjeta Market ? Some of the prominent ...

Tanvex Biopharma Inc. said its U.S. subsidiary, Tanvex Biopharma U.S.A. Inc., received an FDA complete response letter (CRL) on Jan. 3 for its TX-05 BLA, a biosimilar that references Roche AG’s ...

In the trial, patients received neoadjuvant paclitaxel, trastuzumab (Herceptin), and pertuzumab (Perjeta), which was effective in clearing ctDNA. Waks is senior physician and the associate director of ...

For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing. We’ve issued final ...

At the moment, Herceptin is available as a subcutaneous injection but Perjeta needs to be delivered by intravenous infusion – a process that takes hours – and Roche says that means Phesgo is ...

Sales of Perjeta exceeded $1.7 billion in the first half of this year, up 34% compared with the first half of 2018, while the Herceptin, Rituxan, and Avastin all lost traction.